Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Analyst picks & changes

Scios Nova Inc.

(SCIO)

Ehrenreich of Ehrenreich & Co. said he expects partner

Genentech Inc.

to decide whether

Read the full 199 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE